scispace - formally typeset
J

José de la Fuente

Researcher at Spanish National Research Council

Publications -  543
Citations -  26349

José de la Fuente is an academic researcher from Spanish National Research Council. The author has contributed to research in topics: Tick & Anaplasma phagocytophilum. The author has an hindex of 72, co-authored 502 publications receiving 22854 citations. Previous affiliations of José de la Fuente include University of Veterinary Medicine Vienna & Oklahoma State University–Stillwater.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

The natural history of Anaplasma marginale.

TL;DR: Advances in genomics, proteomics, immunology and biochemical and molecular technologies during the last decade have been applied to research on A. marginale and related organisms, and the recent development of a cell culture system for A.marginale has provided a format for studying the pathogen/tick interface.
Journal ArticleDOI

Genomic insights into the Ixodes scapularis tick vector of Lyme disease

Monika Gulia-Nuss, +124 more
TL;DR: Insights from genome analyses into parasitic processes unique to ticks, including host ‘questing', prolonged feeding, cuticle synthesis, blood meal concentration, novel methods of haemoglobin digestion, haem detoxification, vitellogenesis and prolonged off-host survival are reported.
Journal ArticleDOI

Antigens and Alternatives for Control of Anaplasma marginale Infection in Cattle

TL;DR: The recent development of a cell culture system for A. marginale provides a potential source of antigen for the development of improved killed and live vaccines, and the availability of cell culture-derived antigen would eliminate the use of cattle in vaccine production.
Journal ArticleDOI

A ten-year review of commercial vaccine performance for control of tick infestations on cattle.

TL;DR: Commercial tick vaccines for cattle based on the Boophilus microplus Bm86 gut antigen have proven to be a feasible tick control method that offers a cost-effective, environmentally friendly alternative to the use of acaricides.